OMNICELL, INC.
Omnicell, Inc. (NASDAQ: OMCL) is a leading healthcare technology provider focused on empowering autonomous medication management across the continuum of care. The company operates through a single reportable segment and serves hospitals, health systems, specialty pharmacies, long-term care facilities, retail… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What OMNICELL, INC. does
In the company’s own words
Omnicell, Inc. (NASDAQ: OMCL) is a leading healthcare technology provider focused on empowering autonomous medication management across the continuum of care. The company operates through a single reportable segment and serves hospitals, health systems, specialty pharmacies, long-term care facilities, retail pharmacies, and other healthcare settings with an integrated portfolio of medication management solutions powered by its OmniSphere intelligence ecosystem.
The company's core offerings span two primary market categories. Hospital and Health System Solutions provide end-to-end medication management from central pharmacy through point-of-care dispensing, including automated dispensing systems for nursing units and operating rooms, central pharmacy robotics for medication dispensing and IV compounding, and consolidated pharmacy service center automation. Outpatient Pharmacy Solutions extend beyond hospital walls through specialty pharmacy and 340B Program services, medication adherence technologies, and the EnlivenHealth platform for retail and community pharmacies.
Omnicell's product portfolio includes the Titan XT next-generation automated dispensing system, XTExtend console upgrades for existing XT Series cabinets, Central Med Automation Service combining robotics with expert services, IV Compounding Service for sterile medication preparation, and medication adherence solutions including single-dose packaging systems. The company also provides professional services, technical support, customer success programs, and analytics software designed to optimize medication management outcomes and improve operational efficiency.
The company operates globally with solutions for retail pharmacies and hospital automation outside the United States. Omnicell's business model combines hardware automation, cloud-based software platforms, expert services delivered through subscription agreements, and analytics capabilities. The company addresses critical healthcare challenges including workforce shortages, medication safety, regulatory compliance, drug diversion prevention, and medication non-adherence.
The healthcare market context driving demand includes significant consolidation among healthcare providers, rising prescription drug spending exceeding $800 billion annually with specialty medications comprising over half of expenditures, acute workforce shortages particularly in pharmacy technicians and sterile compounding expertise, and increasing regulatory requirements such as Drug Supply Chain Security Act compliance deadlines. These factors position medication management automation as essential infrastructure for healthcare institutions seeking operational resilience and improved clinical outcomes.
Company details
- Sector
- Technology
- Industry
- Computer Hardware
- Headquarters
- FORT WORTH, TX
- Fiscal year end
- December
- CIK
- 926326
- SIC
- 3571
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns OMNICELL, INC. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · OMNICELL, INC.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
OMNICELL, INC.’s bonds, as funds hold them
Funds report holding 1 issues of OMNICELL, INC.’s debt, $18.91M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 1.00%, maturing 2029 to 2029.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do OMNICELL, INC. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of OMNICELL, INC.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in OMNICELL, INC.'s last four quarterly filings that the numbers alone won't show?”